Results 131 to 140 of about 721,847 (303)

Cardiology in 2021 [PDF]

European Heart Journal, 2021
openaire   +2 more sources

Pharmacokinetics, safety, tolerability and fluorescence imaging of nizaracianine triflutate administered in three divided doses to healthy volunteers

British Journal of Clinical Pharmacology, EarlyView.
Aim Fluorescence‐guided surgery enhances intraoperative visualization of anatomical structures. Nizaracianine is a near‐infrared fluorescent agent that is exclusively renally cleared in animal models. It enables real‐time ureteral imaging and identification, potentially reduces risk of injury and facilitates assessment before surgical closure.
Lisanne K. A. Neijenhuis, Cedric M. W. Pesch, John V. Frangioni, Alexander L. Vahrmeijer, Jacobus Burggraaf, Naomi B. Klarenbeek   +5 more
wiley   +1 more source

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

European Heart Journal, 2000
J. Alpert, E. Antman, F. Apple, P. Armstrong, J. Bassand, A. D. Luna, G. Beller, G. Breithardt, B. Chaitman, P. Clemmensen, E. Falk, M. Fishbein, M. Galvani, A. Garson, C. Grines, C. Hamm, U. Hoppe, A. Jaffe, H. Katus, J. Kjekshus, W. Klein, P. Klootwijk, C. Lenfant, D. Levy, R. Levy, R. Luepker, F. Marcus, U. Naslund, M. Ohman, O. Pahlm, P. Poole‐Wilson, R. Popp, K. Pyôrâlà, J. Ravkilde, N. Rehnquist, W. Roberts, R. Roberts, J. Roelandt, L. Rydén, S. Sans, M. Simoons, K. Thygesen, H. Tunstall-Pedoe, R. Underwood, B. Uretsky, F. Werf, L. Voipio‐Pulkki, G. Wagner, L. Wallentin, W. Wijns, D. Wood   +50 more
semanticscholar   +1 more source

Comparative efficacy of GLP‐1 RA, tirzepatide and SGLT‐2 inhibitors in metabolic liver disease: A network meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aim Metabolic liver disease, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis, is a major cause of chronic liver dysfunction worldwide, creating an urgent need for effective treatments. This systematic literature review (SLR) and network meta‐analysis (NMA) systematically reviews and compares the efficacy and safety ...
Andrej Belančić, Christina Antza, Anastasios Poutachidis, Smaro Palaska, Elvira Meni Maria Gkrinia, Andrea Katrin Faour, Yusuf Ziya Sener, Seher Sener, Rehena Sultana   +8 more
wiley   +1 more source

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Journal of the American College of Cardiology, 2020
C. Otto, Rick A. Nishimura, R. Bonow, B. Carabello, J. Erwin, F. Gentile, H. Jneid, E. Krieger, M. Mack, Christopher J. McLeod, P. O'Gara, V. Rigolin, T. Sundt, Annemarie Thompson, Christopher Toly   +14 more
semanticscholar   +1 more source

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice

British Journal of Clinical Pharmacology, EarlyView.
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop, Gertjan J. A. Driessen, Adam F. Cohen, Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Electrophysiological Markers in Hypertrophic Cardiomyopathy: Enhancing Sudden Cardiac Death Risk Prediction with Index of Cardiac Electrophysiological Balance and Its Corrected Variant. [PDF]

Anatol J Cardiol
Balaban İ, Tanyeri S, Karaduman A, Kültürsay B, Gültekin Güner E, Keten MF, Efe SÇ, Alizade E.   +7 more
europepmc   +1 more source

Adverse events in bedaquiline‐ and pretomanid‐based regimens for drug‐resistant tuberculosis from trial, implementation and pharmacovigilance studies

British Journal of Clinical Pharmacology, EarlyView.
Abstract The availability of safety data, particularly concerning adverse events (AEs) associated with the new shorter regimen for drug‐resistant tuberculosis (TB) containing a bedaquiline–pretomanid‐based regimen, is still limited. This systematic review aims to provide a comprehensive and updated analysis of AEs related to this new regimen by ...
Nisa Maria, Annisa Lazuardi Larasati, Indri Yuliani Hamdani, Jin‐Gun Cho, Jan‐Willem C. Alffenaar   +4 more
wiley   +1 more source

Revisiting Subspecialty Training in Cardiology in Indonesia: Structural, Regulatory, and Global Perspectives

The rapid expansion of cardiology as a discipline has prompted the emergence of numerous subspecialties that require structured, competency-based training.
Munawar, Muhammad, Lubis, Anggia Chairuddin, Octaviono, Yudi Her, Setianto, Budi Yuli, Munawar, Andina, Rifqi, Sodiqur, Widito, Sasmojo   +6 more
core   +1 more source

Contraindicated drug–drug interactions and associated adverse drug reactions in an observational cohort study of 4543 paediatric hospitalized patients

British Journal of Clinical Pharmacology, EarlyView.
Abstract Background and Purpose Drug–drug interactions (DDIs) are associated with an increased risk of adverse drug reactions (ADRs). Hospitalized children are particularly vulnerable to DDIs and ADRs due to polypharmacy, frequent use of unlicensed or off‐label medications, and dosing regimens often extrapolated from adult data.
Emilie Laval, Sylvain Goutelle, Inesse Boussaha, Xavier Dode, Yanis Mimouni, Kim An Nguyen, Behrouz Kassai   +6 more
wiley   +1 more source